Schorge JO, Goldstein DP, Bernstein MR, Berkowitz RS. Recent advances in gestational trophoblastic disease. J Reprod Med. 2000 Sep. 45(9):692-700. [Medline].
Ito Y, Maehara K, Kaneki E, et al. Novel nonsense mutation in the NLRP7 gene associated with recurrent hydatidiform mole. Gynecol Obstet Invest. 2015 Nov 26. [Medline].
Wolf NG, Lage JM. Genetic analysis of gestational trophoblastic disease: a review. Semin Oncol. 1995 Apr. 22(2):113-20. [Medline].
Slim R, Mehio A. The genetics of hydatidiform moles: new lights on an ancient disease. Clin Genet. 2007 Jan. 71(1):25-34. [Medline].
Fisher RA, Hodges MD. Genomic imprinting in gestational trophoblastic disease--a review. Placenta. 2003 Apr. 24 Suppl A:S111-8. [Medline].
Al-Hussaini TK, Abd el-Aal DM, Van den Veyver IB. Recurrent pregnancy loss due to familial and non-familial habitual molar pregnancy. Int J Gynaecol Obstet. 2003 Nov. 83(2):179-86. [Medline].
Fallahian M. Familial gestational trophoblastic disease. Placenta. 2003 Aug. 24(7):797-9. [Medline].
Hodges MD, Rees HC, Seckl MJ, et al. Genetic refinement and physical mapping of a biparental complete hydatidiform mole locus on chromosome 19q13.4. J Med Genet. 2003 Aug. 40(8):e95. [Medline].
Lawler SD, Fisher RA, Dent J. A prospective genetic study of complete and partial hydatidiform moles. Am J Obstet Gynecol. 1991 May. 164(5 Pt 1):1270-7. [Medline].
Deveault C, Qian JH, Chebaro W, et al. NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation. Hum Mol Genet. 2009 Mar 1. 18(5):888-97. [Medline].
Watson EJ, Hernandez E, Miyazawa K. Partial hydatidiform moles: a review. Obstet Gynecol Surv. 1987 Sep. 42(9):540-4. [Medline].
Atrash HK, Hogue CJ, Grimes DA. Epidemiology of hydatidiform mole during early gestation. Am J Obstet Gynecol. 1986 Apr. 154(4):906-9. [Medline].
Grimes DA. Epidemiology of gestational trophoblastic disease. Am J Obstet Gynecol. 1984 Oct 1. 150(3):309-18. [Medline].
Jeffers MD, O'Dwyer P, Curran B, Leader M, Gillan JE. Partial hydatidiform mole: a common but underdiagnosed condition. A 3-year retrospective clinicopathological and DNA flow cytometric analysis. Int J Gynecol Pathol. 1993 Oct. 12(4):315-23. [Medline].
Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med. 1994 Mar. 39(3):155-62. [Medline].
Melamed A, Gockley AA, Joseph NT, Sun SY, Clapp MA, Goldstein DP, et al. Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for age. Gynecol Oncol. 2016 Oct. 143 (1):73-76. [Medline].
Bandy LC, Clarke-Pearson DL, Hammond CB. Malignant potential of gestational trophoblastic disease at the extreme ages of reproductive life. Obstet Gynecol. 1984 Sep. 64(3):395-9. [Medline].
Bracken MB. Incidence and aetiology of hydatidiform mole: an epidemiological review. Br J Obstet Gynaecol. 1987 Dec. 94(12):1123-35. [Medline].
Hurteau JA. Gestational trophoblastic disease: management of hydatidiform mole. Clin Obstet Gynecol. 2003 Sep. 46(3):557-69. [Medline].
Vargas R, Barroilhet LM, Esselen K, et al. Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center. J Reprod Med. 2014 May-Jun. 59(5-6):188-94. [Medline].
Gadducci A, Cosio S, Fanucchi A, et al. Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy. Anticancer Res. 2016 Jul. 36 (7):3477-82. [Medline].
Joneborg U, Eloranta S, Johansson AL, Marions L, Weibull CE, Lambe M. Hydatidiform mole and subsequent pregnancy outcome: a population-based cohort study. Am J Obstet Gynecol. 2014 Dec. 211(6):681.e1-7. [Medline].
Lurain JR, Brewer JI, Torok EE, Halpern B. Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol. 1983 Mar 1. 145(5):591-5. [Medline].
Goto S, Yamada A, Ishizuka T, Tomoda Y. Development of postmolar trophoblastic disease after partial molar pregnancy. Gynecol Oncol. 1993 Feb. 48(2):165-70. [Medline].
Cheung AN, Khoo US, Lai CY, et al. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis. Cancer. 2004 Apr 1. 100(7):1411-7. [Medline].
Menczer J, Girtler O, Zajdel L, Glezerman M. Metastatic trophoblastic disease following partial hydatidiform mole: case report and literature review. Gynecol Oncol. 1999 Aug. 74(2):304-7. [Medline].
Twiggs LB, Morrow CP, Schlaerth JB. Acute pulmonary complications of molar pregnancy. Am J Obstet Gynecol. 1979 Sep 15. 135(2):189-94. [Medline].
Sebire NJ, Fisher RA, Foskett M, et al. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG. 2003 Jan. 110(1):22-6. [Medline].
Mangili G, Garavaglia E, Cavoretto P, Gentile C, Scarfone G, Rabaiotti E. Clinical presentation of hydatidiform mole in northern Italy: has it changed in the last 20 years?. Am J Obstet Gynecol. 2008 Mar. 198(3):302.e1-4. [Medline].
Soto-Wright V, Bernstein M, Goldstein DP, Berkowitz RS. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol. 1995 Nov. 86(5):775-9. [Medline].
Sun SY, Melamed A, Goldstein DP, et al. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?. Gynecol Oncol. 2015 Jul. 138 (1):46-9. [Medline].
Amir SM, Osathanondh R, Berkowitz RS, Goldstein DP. Human chorionic gonadotropin and thyroid function in patients with hydatidiform mole. Am J Obstet Gynecol. 1984 Nov 15. 150(6):723-8. [Medline].
Sun SY, Melamed A, Joseph NT, et al. Clinical presentation of complete hydatidiform mole and partial hydatidiform mole at a regional trophoblastic disease center in the United States over the past 2 decades. Int J Gynecol Cancer. 2015 Nov 19. [Medline].
Berkowitz RS, Goldstein DP, Bernstein MR. Natural history of partial molar pregnancy. Obstet Gynecol. 1985 Nov. 66(5):677-81. [Medline].
Fishman DA, Padilla LA, Keh P, Cohen L, Frederiksen M, Lurain JR. Management of twin pregnancies consisting of a complete hydatidiform mole and normal fetus. Obstet Gynecol. 1998 Apr. 91(4):546-50. [Medline].
Steller MA, Genest DR, Bernstein MR, Lage JM, Goldstein DP, Berkowitz RS. Natural history of twin pregnancy with complete hydatidiform mole and coexisting fetus. Obstet Gynecol. 1994 Jan. 83(1):35-42. [Medline].
Florio P, Severi FM, Cobellis L, et al. Serum activin A and inhibin A. New clinical markers for hydatidiform mole. Cancer. 2002 May 15. 94(10):2618-22. [Medline].
Fulop V, Mok SC, Berkowitz RS. Molecular biology of gestational trophoblastic neoplasia: a review. J Reprod Med. 2004 Jun. 49(6):415-22. [Medline].
Fukunaga M. Immunohistochemical characterization of p57(KIP2) expression in early hydatidiform moles. Hum Pathol. 2002 Dec. 33(12):1188-92. [Medline].
Genest DR, Dorfman DM, Castrillon DH. Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification. J Reprod Med. 2002 May. 47(5):342-6. [Medline].
Thaker HM, Berlin A, Tycko B, et al. Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole. J Reprod Med. 2004 Aug. 49(8):630-6. [Medline].
Benachi A, Garritsen HS, Howard CM, Bennett P, Fisk NM. Absence of expression of RhD by human trophoblast cells. Am J Obstet Gynecol. 1998 Feb. 178 (2):294-9. [Medline].
Eddy GL, Schlaerth JB, Nalick RH, Gaddis O Jr, Nakamura RM, Morrow CP. Postmolar trophoblastic disease in women using hormonal contraception with and without estrogen. Obstet Gynecol. 1983 Dec. 62(6):736-40. [Medline].
Agarwal R, Teoh S, Short D, et al. Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study. Lancet. 2012 Jan 14. 379(9811):130-5. [Medline].
Sebire NJ, Foskett M, Short D, et al. Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: evidence for revised protocol of a UK regional trophoblastic disease unit. BJOG. 2007 Jun. 114(6):760-2. [Medline].
Batorfi J, Vegh G, Szepesi J, et al. How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data. Eur J Obstet Gynecol Reprod Biol. 2004 Jan 15. 112(1):95-7. [Medline].
Feltmate CM, Batorfi J, Fulop V, et al. Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation. Obstet Gynecol. 2003 Apr. 101(4):732-6. [Medline].
Garner EI, Lipson E, Bernstein MR, Goldstein DP, Berkowitz RS. Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor. J Reprod Med. 2002 May. 47(5):380-6. [Medline].
Amezcua CA, Bahador A, Naidu YM, Felix JC. Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydatidiform moles. Am J Obstet Gynecol. 2001 Jun. 184(7):1441-6. [Medline].
Wang Q, Fu J, Hu L, Fang F, Xie L, Chen H, et al. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2017 Sep 11. 9:CD007289. [Medline].
Zhao P, Chen Q, Lu W. Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study. BMC Cancer. 2017 Nov 9. 17 (1):733. [Medline].